QuantHealth

QuantHealth is an AI company conducting patient-centric drug simulations to accelerate and de-risk drug development. Over 90% of drugs in clinical development stage fail to reach the market, which accumulates to a $45B/year direct lost to the pharma and biotech industry. Our platform allows our pharma and biotech partners to rapidly run thousands of variations of their clinical trials to optimize the trial design and significantly increase the probability of trial success, all while enabling discovery of new clinical opportunities and optimization strategies. QuantHealth has one the largest integrated datasets that spans the clinical, pharmacological and biological domains together with a proprietary AI platform that can predict patient-response to both approved and novel therapies.
Active
December 2020
11
Software
B2B

$2,600,000

October 26, 2022
Seed
$2,600,000
Shoni Top

Date Announced

Round Stage

Round Size

Lead Investors

atooro-fund-logo
ATOORO FUND
Family Office
2016

Investor

Investor Type

Founded

Funds Raised

bessemer-venture-partners-logo
Bessemer Venture Partners
Venture Capital
1911
$6,000,000,000

Investor

Investor Type

Founded

Funds Raised

investor
Boston Millenia Partners

Investor

Investor Type

Founded

Funds Raised

Artificial Intelligence, Deep Learning
4
G-BERT, Graph Neural Networks (GNN), Transformer

Register Pro to view more

Pro

$50 per month

Sign up to keep browsing

You reached your pageview limit

  • Save profiles to your list
  • Basic search functionality
  • Browse our leading AI database

Select a Table to Export